首页 > 最新文献

Pediatrics最新文献

英文 中文
Caregiver and Child Adverse Childhood Experiences: A Meta-Analysis. 照顾者与儿童不良童年经历:荟萃分析。
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-068578
Jenney Zhu, Audrey-Ann Deneault, Jessica Turgeon, Sheri Madigan

Context: Exposure to adverse childhood experiences (ACEs) is associated with adverse impacts on subsequent generations. The extent to which caregiver ACEs are associated with their child's ACE score is unclear.

Objective: To meta-analytically examine the association between caregiver and child ACE score. Potential moderators of this association were explored.

Data sources: Systematic searches were conducted using MEDLINE, Embase, PsycINFO, and CINHAL from 1998, the year the ACEs questionnaire was published, to February 19, 2024.

Study selection: Inclusion criteria were that the ACEs questionnaire was completed for both caregiver and child, an effect size was available, and the study was published in English.

Data extraction: Variables extracted included sample size and magnitude of association between caregiver ACEs and child ACEs, mean caregiver and child age, sex (% female), race and ethnicity, and informant of ACEs.

Results: Seventeen samples (4872 caregiver-child dyads) met inclusion criterion. Results revealed a large pooled-effect size between caregiver and child ACEs (r = 0.33; 95% CI, 0.25-0.41; P < .001), such that higher caregiver ACEs score was associated with higher child ACEs score. This association was stronger among studies with younger caregivers and studies that utilized caregiver-report compared with child self-report of ACEs.

Limitations: Many studies were conducted in North America with female caregiver samples, limiting generalizability beyond these populations.

Conclusions: Caregiver ACEs were strongly associated with child ACEs. Prevention and intervention efforts for caregivers should be trauma informed and focused on bolstering protective factors that may break cycles of intergenerational risk.

背景:童年不良经历(ace)的暴露与对后代的不良影响有关。照料者的ACE分数与孩子的ACE分数之间的关联程度尚不清楚。目的:对照顾者与儿童ACE评分的关系进行meta分析。对这种关联的潜在调节因素进行了探讨。数据来源:使用MEDLINE、Embase、PsycINFO和CINHAL进行系统检索,检索时间为1998年ace问卷发布之年至2024年2月19日。研究选择:纳入标准为:照顾者和儿童均完成了ace问卷,有效应量,研究以英文发表。数据提取:提取的变量包括样本量和照顾者ace与儿童ace之间的关联程度、照顾者和儿童的平均年龄、性别(女性占比)、种族和民族以及ace的知情者。结果:17份样本(4872对)符合纳入标准。结果显示,照顾者和儿童ace之间存在较大的合并效应(r = 0.33;95% ci, 0.25-0.41;P局限性:许多研究是在北美以女性护理人员为样本进行的,限制了这些人群之外的推广。结论:照顾者ace与儿童ace密切相关。护理人员的预防和干预工作应了解创伤,并侧重于加强可能打破代际风险循环的保护因素。
{"title":"Caregiver and Child Adverse Childhood Experiences: A Meta-Analysis.","authors":"Jenney Zhu, Audrey-Ann Deneault, Jessica Turgeon, Sheri Madigan","doi":"10.1542/peds.2024-068578","DOIUrl":"10.1542/peds.2024-068578","url":null,"abstract":"<p><strong>Context: </strong>Exposure to adverse childhood experiences (ACEs) is associated with adverse impacts on subsequent generations. The extent to which caregiver ACEs are associated with their child's ACE score is unclear.</p><p><strong>Objective: </strong>To meta-analytically examine the association between caregiver and child ACE score. Potential moderators of this association were explored.</p><p><strong>Data sources: </strong>Systematic searches were conducted using MEDLINE, Embase, PsycINFO, and CINHAL from 1998, the year the ACEs questionnaire was published, to February 19, 2024.</p><p><strong>Study selection: </strong>Inclusion criteria were that the ACEs questionnaire was completed for both caregiver and child, an effect size was available, and the study was published in English.</p><p><strong>Data extraction: </strong>Variables extracted included sample size and magnitude of association between caregiver ACEs and child ACEs, mean caregiver and child age, sex (% female), race and ethnicity, and informant of ACEs.</p><p><strong>Results: </strong>Seventeen samples (4872 caregiver-child dyads) met inclusion criterion. Results revealed a large pooled-effect size between caregiver and child ACEs (r = 0.33; 95% CI, 0.25-0.41; P < .001), such that higher caregiver ACEs score was associated with higher child ACEs score. This association was stronger among studies with younger caregivers and studies that utilized caregiver-report compared with child self-report of ACEs.</p><p><strong>Limitations: </strong>Many studies were conducted in North America with female caregiver samples, limiting generalizability beyond these populations.</p><p><strong>Conclusions: </strong>Caregiver ACEs were strongly associated with child ACEs. Prevention and intervention efforts for caregivers should be trauma informed and focused on bolstering protective factors that may break cycles of intergenerational risk.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142971778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late-Onset Sepsis Among Extremely Preterm Infants During the COVID-19 Pandemic.
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-067675
Sagori Mukhopadhyay, David A Kaufman, Shampa Saha, Karen M Puopolo, Dustin D Flannery, Kristin E D Weimer, Rachel G Greenberg, Pablo J Sanchez, Eric C Eichenwald, Charles M Cotten, Barbara J Stoll, Abbot Laptook

Objectives: To compare incidence of late-onset sepsis (LOS) among extremely preterm infants before and during the COVID-19 pandemic.

Methods: Multicenter cohort study of infants with birthweight 401 to 1000 g or gestational age 22 to 28 weeks. LOS was defined as a bacterial or fungal pathogen isolated from blood or cerebrospinal fluid culture obtained after 72 hours of age. Primary outcome was LOS incidence calculated as incidence proportion (LOS cases among all admissions) and incidence rate (LOS events/1000 patient days). A multivariable Poisson regression model was used to compare the adjusted risk of LOS incidence proportion before (1/1/18-3/31/20) and during the pandemic (4/1/20-12/31/21). An interrupted time series analysis using a generalized linear mixed model with center as a random effect was used to compare LOS incidence rates during the 2 periods.

Results: Among 6509 eligible infants, LOS incidence proportion was not different before (18.2%) and during the pandemic (16.9%; P = .18). The adjusted relative risk (95% CI) for LOS was 0.93 (0.82-1.05) and for LOS or mortality was 0.98 (0.88-1.08) during the pandemic compared to the period before the pandemic. In the interrupted time series analysis, there was no significant change in LOS incidence rates at the start of the pandemic (0.219, 95% CI, -0.453 to 0.891) or microbiology of LOS, and change in trends of LOS incidence rates before and during the pandemic was not significant (-0.005, 95% CI, -0.025 to 0.015).

Conclusions: In a large multicenter study of extremely preterm infants, rates of LOS remained unchanged during the pandemic.

{"title":"Late-Onset Sepsis Among Extremely Preterm Infants During the COVID-19 Pandemic.","authors":"Sagori Mukhopadhyay, David A Kaufman, Shampa Saha, Karen M Puopolo, Dustin D Flannery, Kristin E D Weimer, Rachel G Greenberg, Pablo J Sanchez, Eric C Eichenwald, Charles M Cotten, Barbara J Stoll, Abbot Laptook","doi":"10.1542/peds.2024-067675","DOIUrl":"10.1542/peds.2024-067675","url":null,"abstract":"<p><p></p><p><strong>Objectives: </strong>To compare incidence of late-onset sepsis (LOS) among extremely preterm infants before and during the COVID-19 pandemic.</p><p><strong>Methods: </strong>Multicenter cohort study of infants with birthweight 401 to 1000 g or gestational age 22 to 28 weeks. LOS was defined as a bacterial or fungal pathogen isolated from blood or cerebrospinal fluid culture obtained after 72 hours of age. Primary outcome was LOS incidence calculated as incidence proportion (LOS cases among all admissions) and incidence rate (LOS events/1000 patient days). A multivariable Poisson regression model was used to compare the adjusted risk of LOS incidence proportion before (1/1/18-3/31/20) and during the pandemic (4/1/20-12/31/21). An interrupted time series analysis using a generalized linear mixed model with center as a random effect was used to compare LOS incidence rates during the 2 periods.</p><p><strong>Results: </strong>Among 6509 eligible infants, LOS incidence proportion was not different before (18.2%) and during the pandemic (16.9%; P = .18). The adjusted relative risk (95% CI) for LOS was 0.93 (0.82-1.05) and for LOS or mortality was 0.98 (0.88-1.08) during the pandemic compared to the period before the pandemic. In the interrupted time series analysis, there was no significant change in LOS incidence rates at the start of the pandemic (0.219, 95% CI, -0.453 to 0.891) or microbiology of LOS, and change in trends of LOS incidence rates before and during the pandemic was not significant (-0.005, 95% CI, -0.025 to 0.015).</p><p><strong>Conclusions: </strong>In a large multicenter study of extremely preterm infants, rates of LOS remained unchanged during the pandemic.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Academic Achievement of Children With Neurofibromatosis Type 1.
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-067016
Yang Hou, Xiaoli Zong, Xian Wu, Dan Liu, Pamela L Wolters, Jennifer Janusz, Karin S Walsh, Stephanie M Morris, Jonathan M Payne, Natalie Pride, Shruti Garg, Louise Robinson, Peter L Stavinoha

Background and objectives: Learning difficulties are frequently reported in children with neurofibromatosis type 1 (NF1), yet little is known about the extent and predictors of their academic functions across ages. We aimed to examine the developmental patterns of academic achievement in these children from childhood to adolescence and how these patterns differ across demographic and NF1-related disease factors.

Methods: This cross-sectional study integrated data of 1512 children with NF1 (mean age, 11.2 years, SD, 3.62, range, 3-18, 46.5% female patients) from 8 institutions. Academic functioning was assessed with Woodcock-Johnson Tests of Achievement or the Wechsler Individual Achievement Test. Data were analyzed primarily using time-varying effect modeling.

Results: Participants' academic achievement was significantly lower than the normative means across ages, and the gap widened from middle childhood to midadolescence. Academic age trends varied across academic domains and demographic and disease factors. Male patients demonstrated larger deviations in math at midchildhood and in reading and writing between midchildhood and midadolescence. Children with lower parental education demonstrated larger deviations in math, reading, and writing between midchildhood and midadolescence. Children with familial NF1 demonstrated larger deviations in math at midchildhood and mid-to-late-adolescence, and in reading and writing between midchildhood and midadolescence.

Conclusions: Academic difficulties in children with NF1 emerge early and worsen with age. The findings also highlight the variability within this population across demographic and disease factors. The age-specific estimates of academic functions can serve as the first NF1-specific academic norms, providing useful insights for future research and practice.

{"title":"Academic Achievement of Children With Neurofibromatosis Type 1.","authors":"Yang Hou, Xiaoli Zong, Xian Wu, Dan Liu, Pamela L Wolters, Jennifer Janusz, Karin S Walsh, Stephanie M Morris, Jonathan M Payne, Natalie Pride, Shruti Garg, Louise Robinson, Peter L Stavinoha","doi":"10.1542/peds.2024-067016","DOIUrl":"10.1542/peds.2024-067016","url":null,"abstract":"<p><p></p><p><strong>Background and objectives: </strong>Learning difficulties are frequently reported in children with neurofibromatosis type 1 (NF1), yet little is known about the extent and predictors of their academic functions across ages. We aimed to examine the developmental patterns of academic achievement in these children from childhood to adolescence and how these patterns differ across demographic and NF1-related disease factors.</p><p><strong>Methods: </strong>This cross-sectional study integrated data of 1512 children with NF1 (mean age, 11.2 years, SD, 3.62, range, 3-18, 46.5% female patients) from 8 institutions. Academic functioning was assessed with Woodcock-Johnson Tests of Achievement or the Wechsler Individual Achievement Test. Data were analyzed primarily using time-varying effect modeling.</p><p><strong>Results: </strong>Participants' academic achievement was significantly lower than the normative means across ages, and the gap widened from middle childhood to midadolescence. Academic age trends varied across academic domains and demographic and disease factors. Male patients demonstrated larger deviations in math at midchildhood and in reading and writing between midchildhood and midadolescence. Children with lower parental education demonstrated larger deviations in math, reading, and writing between midchildhood and midadolescence. Children with familial NF1 demonstrated larger deviations in math at midchildhood and mid-to-late-adolescence, and in reading and writing between midchildhood and midadolescence.</p><p><strong>Conclusions: </strong>Academic difficulties in children with NF1 emerge early and worsen with age. The findings also highlight the variability within this population across demographic and disease factors. The age-specific estimates of academic functions can serve as the first NF1-specific academic norms, providing useful insights for future research and practice.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Home Health Care Research for Children With Disability and Medical Complexity. 针对残疾儿童和医疗复杂性儿童的家庭医疗保健研究。
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-067966
Carolyn Foster, Elaine Lin, James A Feinstein, Rebecca Seltzer, Robert J Graham, Cara Coleman, Erin Ward, Ryan J Coller, Sarah Sobotka, Jay G Berry

Pediatric home health care represents a vital system of care for children with disability and medical complexity, encompassing services provided by family caregivers and nonfamily home health care providers and the use of durable medical equipment and supplies. Home health care is medically necessary for the physiologic health of children with disability and medical complexity and for their participation and function within home, school, and community settings. While the study of pediatric home health care in the United States has increased in the last decade, its research remains primarily methodologically limited to observational studies. Dedicated funding and research efforts are needed to transform American home health care research to address multifaceted outcomes valued by families and providers as well as payers and government programs. In this paper, we review the recent literature in pediatric home health care and then propose an actional agenda that could address its missing evidence base. We posit that pediatricians should partner with family caregiving experts and patients to advance knowledge about child and family health outcomes, home health care use, new models of care, and optimal approaches to education and training while also considering meaningful approaches to address disparities. The creation of an American pediatric home health care data-sharing consortium, patient registry, and reproducible access and quality measures is also needed. Most importantly, efforts should center on patient- and family-centered health priorities, with the goal of ensuring equitable outcomes for every child and family.

儿科家庭保健是残疾儿童和医疗复杂儿童的重要保健系统,包括由家庭照顾者和非家庭家庭保健提供者提供的服务,以及使用耐用的医疗设备和用品。家庭保健在医学上对于残疾儿童的生理健康和医疗复杂性以及他们在家庭、学校和社区环境中的参与和功能是必要的。虽然在过去十年中,美国对儿科家庭保健的研究有所增加,但其研究在方法学上仍主要局限于观察性研究。需要专门的资金和研究工作来改变美国家庭医疗保健研究,以解决家庭和提供者以及付款人和政府项目所重视的多方面结果。在本文中,我们回顾了儿科家庭保健的最新文献,然后提出了一个行动议程,可以解决其缺失的证据基础。我们认为,儿科医生应该与家庭护理专家和患者合作,提高对儿童和家庭健康结果、家庭保健使用、新的护理模式和最佳教育和培训方法的认识,同时也考虑有意义的方法来解决差距。还需要建立一个美国儿科家庭卫生保健数据共享联盟、患者登记、可重复访问和质量测量。最重要的是,努力应以病人和家庭为中心的卫生优先事项为中心,目标是确保每个儿童和家庭获得公平的结果。
{"title":"Home Health Care Research for Children With Disability and Medical Complexity.","authors":"Carolyn Foster, Elaine Lin, James A Feinstein, Rebecca Seltzer, Robert J Graham, Cara Coleman, Erin Ward, Ryan J Coller, Sarah Sobotka, Jay G Berry","doi":"10.1542/peds.2024-067966","DOIUrl":"10.1542/peds.2024-067966","url":null,"abstract":"<p><p>Pediatric home health care represents a vital system of care for children with disability and medical complexity, encompassing services provided by family caregivers and nonfamily home health care providers and the use of durable medical equipment and supplies. Home health care is medically necessary for the physiologic health of children with disability and medical complexity and for their participation and function within home, school, and community settings. While the study of pediatric home health care in the United States has increased in the last decade, its research remains primarily methodologically limited to observational studies. Dedicated funding and research efforts are needed to transform American home health care research to address multifaceted outcomes valued by families and providers as well as payers and government programs. In this paper, we review the recent literature in pediatric home health care and then propose an actional agenda that could address its missing evidence base. We posit that pediatricians should partner with family caregiving experts and patients to advance knowledge about child and family health outcomes, home health care use, new models of care, and optimal approaches to education and training while also considering meaningful approaches to address disparities. The creation of an American pediatric home health care data-sharing consortium, patient registry, and reproducible access and quality measures is also needed. Most importantly, efforts should center on patient- and family-centered health priorities, with the goal of ensuring equitable outcomes for every child and family.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Pediatric Functional Abdominal Pain Disorders: A Meta-Analysis. 儿童功能性腹痛疾病的流行病学:一项荟萃分析。
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-067677
Nicolaas Koen Vermeijden, Leilani de Silva, Supun Manathunga, Daphne Spoolder, Judith Korterink, Arine Vlieger, Shaman Rajindrajith, Marc Benninga

Context: Functional abdominal pain disorders (FAPDs) are debilitating disorders with unknown current prevalence.

Objective: To estimate global prevalence rates of FAPDs, their entities, and variations by diagnostic criteria, geography, gender, and age.

Data sources: Medline, Embase, CINAHL, PsycInfo, and Cochrane Library were searched through October 14, 2024.

Study selection: Epidemiological studies of birth cohorts, school based, and from general population samples reporting FAPD prevalence in children (aged 4-18 years) using the Rome criteria.

Data extraction: Two researchers independently performed screening, data extraction, and quality assessment.

Results: A total of 66 studies, encompassing 201 134 participants from 29 countries, were included. The estimated global pooled prevalence of FAPDs was 11.7% (95% CI, 10.5%-13.1%). The most prevalent type was irritable bowel syndrome (5.8%; 95% CI, 4.5-7.4%), while functional abdominal pain-not otherwise specified was least prevalent (1.2%; 95% CI, 0.7%-2.1%)). Prevalence was highest using Rome III (13.2%; 95% CI, 11.3%-15.3%) and lowest under Rome IV criteria (9.0%; 95% CI, 6.7%-12.0%; P = .05). Girls had higher prevalence (14.4%; 95% CI, 12.5%-16.6%) than boys (9.4%; 95% CI, 7.8%-11.4%; P < .01). FAPDs were nonsignificantly more prevalent in Asia (13.0%; 95% CI, 10.4%-16.3%) compared to Europe (8.3%; 95% CI, 6.4%-10.7%) and North America (7.7%; 95% CI, 4.3-13.6; P = .09). No differences by age (P = .14) were recorded. Contributing factors include anxiety, depression, stress, negative life events, and poor sleep.

Limitations: Language restrictions, significant interstudy heterogeneity, and underrepresentation from Africa.

Conclusions and relevance: FAPDs affect over 1 in 9 children worldwide, with higher prevalence in girls and those with psychological stressors.

背景:功能性腹痛障碍(FAPDs)是目前患病率未知的衰弱性疾病。目的:估计fapd的全球患病率,其实体,以及诊断标准、地理、性别和年龄的变化。数据来源:Medline, Embase, CINAHL, PsycInfo, Cochrane Library检索截止至2024年10月14日。研究选择:采用罗马标准对出生队列、学校和一般人群样本进行流行病学研究,报告4-18岁儿童FAPD患病率。数据提取:两名研究人员独立进行筛选、数据提取和质量评估。结果:共纳入66项研究,包括来自29个国家的201134名参与者。估计fapd的全球总患病率为11.7% (95% CI, 10.5%-13.1%)。最常见的类型是肠易激综合征(5.8%;95% CI, 4.5-7.4%),而功能性腹痛-未另行说明的发生率最低(1.2%;95% ci, 0.7%-2.1%)。使用Rome III时患病率最高(13.2%;95% CI, 11.3%-15.3%),在罗马IV标准下最低(9.0%;95% ci, 6.7%-12.0%;p = 0.05)。女孩的患病率较高(14.4%;95% CI, 12.5%-16.6%)高于男孩(9.4%;95% ci, 7.8%-11.4%;P限制:语言限制,显著的研究间异质性,非洲代表性不足。结论和相关性:fapd影响全球超过九分之一的儿童,女孩和有心理压力源的儿童患病率更高。
{"title":"Epidemiology of Pediatric Functional Abdominal Pain Disorders: A Meta-Analysis.","authors":"Nicolaas Koen Vermeijden, Leilani de Silva, Supun Manathunga, Daphne Spoolder, Judith Korterink, Arine Vlieger, Shaman Rajindrajith, Marc Benninga","doi":"10.1542/peds.2024-067677","DOIUrl":"10.1542/peds.2024-067677","url":null,"abstract":"<p><strong>Context: </strong>Functional abdominal pain disorders (FAPDs) are debilitating disorders with unknown current prevalence.</p><p><strong>Objective: </strong>To estimate global prevalence rates of FAPDs, their entities, and variations by diagnostic criteria, geography, gender, and age.</p><p><strong>Data sources: </strong>Medline, Embase, CINAHL, PsycInfo, and Cochrane Library were searched through October 14, 2024.</p><p><strong>Study selection: </strong>Epidemiological studies of birth cohorts, school based, and from general population samples reporting FAPD prevalence in children (aged 4-18 years) using the Rome criteria.</p><p><strong>Data extraction: </strong>Two researchers independently performed screening, data extraction, and quality assessment.</p><p><strong>Results: </strong>A total of 66 studies, encompassing 201 134 participants from 29 countries, were included. The estimated global pooled prevalence of FAPDs was 11.7% (95% CI, 10.5%-13.1%). The most prevalent type was irritable bowel syndrome (5.8%; 95% CI, 4.5-7.4%), while functional abdominal pain-not otherwise specified was least prevalent (1.2%; 95% CI, 0.7%-2.1%)). Prevalence was highest using Rome III (13.2%; 95% CI, 11.3%-15.3%) and lowest under Rome IV criteria (9.0%; 95% CI, 6.7%-12.0%; P = .05). Girls had higher prevalence (14.4%; 95% CI, 12.5%-16.6%) than boys (9.4%; 95% CI, 7.8%-11.4%; P < .01). FAPDs were nonsignificantly more prevalent in Asia (13.0%; 95% CI, 10.4%-16.3%) compared to Europe (8.3%; 95% CI, 6.4%-10.7%) and North America (7.7%; 95% CI, 4.3-13.6; P = .09). No differences by age (P = .14) were recorded. Contributing factors include anxiety, depression, stress, negative life events, and poor sleep.</p><p><strong>Limitations: </strong>Language restrictions, significant interstudy heterogeneity, and underrepresentation from Africa.</p><p><strong>Conclusions and relevance: </strong>FAPDs affect over 1 in 9 children worldwide, with higher prevalence in girls and those with psychological stressors.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142952908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recommended Childhood and Adolescent Immunization Schedule: United States, 2025: Policy Statement. 推荐的儿童和青少年免疫接种时间表:美国,2025 年:政策声明。
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-02-01 DOI: 10.1542/peds.2024-069987
{"title":"Recommended Childhood and Adolescent Immunization Schedule: United States, 2025: Policy Statement.","authors":"","doi":"10.1542/peds.2024-069987","DOIUrl":"10.1542/peds.2024-069987","url":null,"abstract":"","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Instruction for Use: Developmental Milestones in Down Syndrome.
IF 8 2区 医学 Q1 PEDIATRICS Pub Date : 2025-01-29 DOI: 10.1542/peds.2024-069954c
Noemi Spinazzi
{"title":"Instruction for Use: Developmental Milestones in Down Syndrome.","authors":"Noemi Spinazzi","doi":"10.1542/peds.2024-069954c","DOIUrl":"https://doi.org/10.1542/peds.2024-069954c","url":null,"abstract":"","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":"28 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concern About the Validity of These Norms as Representing a Population Sample.
IF 8 2区 医学 Q1 PEDIATRICS Pub Date : 2025-01-29 DOI: 10.1542/peds.2024-069954a
Susan Buckley
{"title":"Concern About the Validity of These Norms as Representing a Population Sample.","authors":"Susan Buckley","doi":"10.1542/peds.2024-069954a","DOIUrl":"https://doi.org/10.1542/peds.2024-069954a","url":null,"abstract":"","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":"36 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Response to Comments.
IF 6.2 2区 医学 Q1 PEDIATRICS Pub Date : 2025-01-29 DOI: 10.1542/peds.2024-069954D
Nicole Baumer, Rafael DePillis, Katherine Pawlowski, Bo Zhang, Maitreyi Mazumdar
{"title":"Author Response to Comments.","authors":"Nicole Baumer, Rafael DePillis, Katherine Pawlowski, Bo Zhang, Maitreyi Mazumdar","doi":"10.1542/peds.2024-069954D","DOIUrl":"https://doi.org/10.1542/peds.2024-069954D","url":null,"abstract":"","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":" ","pages":""},"PeriodicalIF":6.2,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143060132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guided Self-Help vs Group Treatment for Children With Obesity: A Randomized Clinical Trial.
IF 8 2区 医学 Q1 PEDIATRICS Pub Date : 2025-01-29 DOI: 10.1542/peds.2024-066561
Kerri N Boutelle,Kyung E Rhee,David R Strong,Michael A Manzano,Rebecca S Bernard,Dawn M Eichen,Cheryl C A Anderson,Bess H Marcus,Natacha Akshoomoff,Scott J Crow
BACKGROUND AND OBJECTIVESFamily-based behavioral treatment (FBT) for children with obesity is provided in weekly parent and child groups over 6 months. A guided self-help FBT program (gshFBT) is provided to the dyad in short meetings. Both interventions provide the same content; however, gshFBT provides this content in less time (FBT = 23 hours, gshFBT = 5.3 hours). This study aimed to evaluate whether gshFBT is noninferior to FBT on child weight loss and cost-effectiveness.METHODS150 children aged between 7.0 and 12.9 years with a BMI between the 85th and 99.9th percentile and their parent were recruited and randomized to a 6-month program of gshFBT (n = 75) or FBT (n = 75) and were followed 12 months post-treatment.RESULTSA total of 150 children (mean age = 10.1 years, 49% female, mean BMIz = 2.09) and their parent (mean age = 41.5 years, 87% female, 45% Hispanic, 37% White non-Hispanic, 9.7% Asian, 4.8% Black, 7.3% other) were recruited from the San Diego Metropolitan area. Joint LME models showed that gshFBT was noninferior to FBT on child weight loss (ΔBMIz = -0.02 [90% credible interval [CI] -0.08-0.05, P = .65]; ΔBMIp95% = -1.57 [90% CI -4.46-1.31, P = .28]) and cost less (cost/dyad gshFBT = $1498; FBT = $2775).CONCLUSIONThe gshFBT program provided similar weight losses for children with less contact hours and with lower cost than FBT. The reduced time and ease of scheduling for the family in gshFBT will allow for an increased reach of treatment to a greater proportion of families in need.
{"title":"Guided Self-Help vs Group Treatment for Children With Obesity: A Randomized Clinical Trial.","authors":"Kerri N Boutelle,Kyung E Rhee,David R Strong,Michael A Manzano,Rebecca S Bernard,Dawn M Eichen,Cheryl C A Anderson,Bess H Marcus,Natacha Akshoomoff,Scott J Crow","doi":"10.1542/peds.2024-066561","DOIUrl":"https://doi.org/10.1542/peds.2024-066561","url":null,"abstract":"BACKGROUND AND OBJECTIVESFamily-based behavioral treatment (FBT) for children with obesity is provided in weekly parent and child groups over 6 months. A guided self-help FBT program (gshFBT) is provided to the dyad in short meetings. Both interventions provide the same content; however, gshFBT provides this content in less time (FBT = 23 hours, gshFBT = 5.3 hours). This study aimed to evaluate whether gshFBT is noninferior to FBT on child weight loss and cost-effectiveness.METHODS150 children aged between 7.0 and 12.9 years with a BMI between the 85th and 99.9th percentile and their parent were recruited and randomized to a 6-month program of gshFBT (n = 75) or FBT (n = 75) and were followed 12 months post-treatment.RESULTSA total of 150 children (mean age = 10.1 years, 49% female, mean BMIz = 2.09) and their parent (mean age = 41.5 years, 87% female, 45% Hispanic, 37% White non-Hispanic, 9.7% Asian, 4.8% Black, 7.3% other) were recruited from the San Diego Metropolitan area. Joint LME models showed that gshFBT was noninferior to FBT on child weight loss (ΔBMIz = -0.02 [90% credible interval [CI] -0.08-0.05, P = .65]; ΔBMIp95% = -1.57 [90% CI -4.46-1.31, P = .28]) and cost less (cost/dyad gshFBT = $1498; FBT = $2775).CONCLUSIONThe gshFBT program provided similar weight losses for children with less contact hours and with lower cost than FBT. The reduced time and ease of scheduling for the family in gshFBT will allow for an increased reach of treatment to a greater proportion of families in need.","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":"48 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1